DEFA14A: Processa Pharma Changes Shareholder Meeting Location

Processa Pharmaceuticals, Inc. announced a change in the physical location for its upcoming 2025 Special Meeting of Stockholders.

Summary

• Processa Pharmaceuticals, Inc. (the Company) filed a proxy statement on August 13, 2025, in connection with its 2025 Special Meeting of Stockholders.
• On August 25, 2025, the Company's board of directors changed the location of this Special Meeting of Stockholders.
• The meeting will now be held at 594 East Colorado Blvd. Suite 200 Pasadena, CA 91101, instead of the previously announced 601 21st Street, Suite 300, Vero Beach, FL 32960.

Sentiment

Score: 5

Explanation: The filing reports a neutral administrative change regarding the location of a shareholder meeting, with no direct positive or negative financial implications.

Future Outlook

The filing does not contain any forward-looking statements or guidance beyond the logistical change for the upcoming Special Meeting of Stockholders.

Management Comments

• The report was signed by George Ng, Chief Executive Officer, on behalf of Processa Pharmaceuticals, Inc.

Industry Context

This administrative update is a routine logistical adjustment for a corporate event and does not reflect broader industry trends or competitive dynamics within the pharmaceutical sector.

Stakeholder Impact

• Shareholders planning to attend the 2025 Special Meeting of Stockholders in person will need to note the new location in Pasadena, CA.

Next Steps

• The 2025 Special Meeting of Stockholders will proceed at the newly announced location.

Key Dates

Keywords

Processa Pharmaceuticals, PCSA, Special Meeting, Stockholders Meeting, Meeting Location Change, Corporate Governance, SEC Filing, Form 8-K